LBLaura Beretta

Laura Beretta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Laura Beretta has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Annabelle Grolleau

    Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan 48109, USA

    3 shared publications
  • Samir Hanash

    Department of Pediatrics, University of Michigan, Ann Arbor, Michigan 48109, USA

    3 shared publications
  • Andoni Echaniz-Laguna

    Laboratoire de Neurogénétique Moléculaire, INSERM E 9913, Genopole, Evry, France

    1 shared publication
  • Annie Abadie

    Institut National de la Santé et de la Recherche Médicale (INSERM), Curie Institute, Paris, France

    1 shared publication
  • Bruce Richardson

    Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 365, Institut Curie, Paris, France2Department of Internal Medicine,3Department of Pediatrics, and4Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA5Department of Medicine, Veterans Affairs Medical Center, Ann Arbor, Michigan, USA

    1 shared publication
  • Bérengère Pradet-Balade

    From the ‡Department of Microbiology and Immunology, and the ¶Department of Pediatrics, University of Michigan, Ann Arbor, Michigan 48109 and the §Department of Immunology and Oncology, Centro Nacional de Biotecnologia, Consejo Superior de Investigaciones Cientı́ficas, Madrid E-28049, Spain

    1 shared publication

Latest Publications

  • TRANSLATIONAL CONTROL IN T LYMPHOCYTES

    by Laura Beretta

    Translational control is an important but relatively unappreciated mechanism that regulates levels of protein products. In addition to a global translational control that regulates the cell's response to external stimuli such as growth factors, cytokines, stress, and viral infections, selective translational control has recently been demonstrated to affect many genes related to growth and apoptotic processes. Translational infidelity has recently been suggested as a new mechanism of T cell dysregulation in SLE. This review discusses current data on translational control of T cell biology and the central aspect of translational control in the signalling pathway leading to T cell proliferation, apoptotic response, and cytokine production. The utility for global analysis by genomics to study translational control of T cell gene expression is also discussed.


  • Integrated Genomic and Proteomic Analysis of Signaling Pathways in Dendritic Cell Differentiation and Maturation

    by John Richards, François LE Naour, Samir Hanash, Laura Beretta

    Abstract:Dendritic cells (DCs) are antigen‐presenting cells that play a major role in initiating primary immune responses. Their phenotypic and functional characteristics are intimately linked to their stage of maturation. The specific biochemical pathways and genes whose expression mediates differentiation of progenitors to DCs and their maturation are largely undefined. We recently utilized two approaches, DNA microarrays and proteomics, to analyze the expression profile of human CD14+blood monocytes and their derived DCs. Approximately 4% of the genes or proteins expressed were found to be regulated during DC differentiation. Most of these genes were not previously associated with DCs and included genes highly relevant to DC functions (genes involved in antigen presentation, cell adhesion and motility, lipid metabolism). Genes involved in specific signaling pathways, including IκBα, PPAR‐γ and C/EBPα as well as two members of the family of transcription factors, interferon regulatory factors (IRFs), were also modified. Modulation of IRF gene expression is of particular interest because of their functional roles in innate and adaptive immune responses. IRF‐family members control the expression of proteins that include type‐1 interferons, interleukin‐12, interleukin‐15, MHC molecules and adhesion molecules. They have also been found to play an important role in lymphocyte development. In contrast to DC differentiation, very few genes were modified at the transcript level during DC maturation as determined by microarray experiments. Further analysis suggested that DC maturation is largely controlled by posttranscriptional and posttranslational modifications. The use of proteomics is therefore necessary for a full comprehension of DC maturation process.


  • Open Access

    Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and Proteomics

    by Annabelle Grolleau, Jessica Bowman, Bérengère Pradet-Balade, Eric Puravs, Samir Hanash, Jose A. Garcia-Sanz, Laura Beretta


  • Open Access

    Profiling Changes in Gene Expression during Differentiation and Maturation of Monocyte-derived Dendritic Cells Using Both Oligonucleotide Microarrays and Proteomics

    by François Le Naour, Lyndon Hohenkirk, Annabelle Grolleau, David E. Misek, Pascal Lescure, James D. Geiger, Samir Hanash, Laura Beretta


  • Open Access

    Proteomic-Based Approach for the Identification of Tumor Markers Associated with Hepatocellular Carcinoma

    by Philip Shalhoub, Sarah Kern, Sophie Girard, Laura Beretta

    There is increasing evidence for an immune response to cancer in humans, demonstrated in part by the identification of autoantibodies to tumor antigens. The identification of panels of tumor antigens that elicit a humoral response may have utility in cancer screening, diagnosis or in establishing prognosis. Several approaches are currently available for the identification of tumor antigens. We have used a proteomic-based approach for the identification of tumor antigens that induce an antibody response which we have applied to hepatocellular carcinoma, a major type of cancer worldwide. Two-dimensional gel electrophoresis allows simultaneous separation of several thousand individual proteins from tumor tissue or tumor cell lines. Proteins eliciting a humoral response in HCC were identified by 2-D Western blotting using sera from patients with hepatocellular carcinoma, followed by mass spectrometry analysis and database search. The common occurrence of autoantibodies to specific proteins may have utility for HCC screening and diagnosis.


  • Open Access

    Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients

    by Annabelle Grolleau, Mariana J. Kaplan, Samir M. Hanash, Laura Beretta, Bruce Richardson

    Activation of peripheral blood T cells results in a rapid and substantial rise in translation rates and proliferation, but proliferation in response to mitogen stimulation is impaired in systemic lupus erythematosus (SLE). We have investigated translation rates and initiation factor activities in T cells from SLE patients in response to activating signals. Activation by PMA plus ionomycin strongly increased protein synthesis in control T cells but not in T cells from SLE patients. The rate of protein synthesis is known to be strongly dependent on the activity of two eukaryotic translation initiation factors, eIF4E and eIF2α. We show that following stimulation, eIF4E expression and phosphorylation increased equivalently in control and SLE T cells. Expression of eIF4E interacting proteins — eIF4G, an inducer, and 4E-BP1 and 4E-BP2, two specific repressors of eIF4E function — and the phosphorylation level of 4E-BP1, were all identical in control and SLE T cells. In contrast, the protein kinase PKR, which is responsible for the phosphorylation and consequent inhibition of eIF2α activity, was specifically overexpressed in activated SLE T cells, correlating with an increase in eIF2α phosphorylation. Therefore, high expression of PKR and subsequent eIF2α phosphorylation is likely responsible, at least in part, for impaired translational and proliferative responses to mitogens in T cells from SLE patients.


  • Open Access

    Interferons and IRF-1 Induce Expression of the Survival Motor Neuron (SMN) Genes

    by Sophie Baron-Delage, Annie Abadie, Andoni Echaniz-Laguna, Judith Melki, Laura Beretta

    Spinal muscular atrophy (SMA) is a common recessive disorder, characterized by degeneration of motor neurons of the spinal cord. Deletions, conversions, or mutations of the survival motor neuron gene (SMN) are responsible for SMA. A highly homologous centromeric copy of the SMN gene (SMNc) remains intact in SMA patients. However, there is an inverse correlation between the amount of the SMNc gene product and the clinical severity of the disease. An understanding of SMN and SMNc gene regulation is, therefore, an important step towards therapy for SMA. We identified a candidate Interferon-Stimulated Response Element (ISRE), overlapping with an Interferon Regulatory Factors binding motif (IRF-E) in the promoter region of SMN and SMNc genes. Both ISRE and IRF-E motifs are involved in mediating transcriptional induction of interferon-stimulated gene expression. We, therefore, investigated whether SMN and SMNc genes were regulated by interferons (IFN). Here we show that both IFN-β and IFN-γ rapidly induced SMN and SMNc mRNA and protein expression in various cell lines. The transcription factor IRF-1 bound to the candidate ISRE/IRF-E sequence of SMN and SMNc genes in vitro and overexpression of IRF-1 induced expression of both genes in transfection assays. IRF-1 is, therefore, at least in part responsible for the induction of SMN and SMNc by IFNs. In primary culture of fibroblasts from SMA patients, IFN-β and IFN-γ induced SMNc gene expression and restored protein defect.